Browse by Author Tsang, FH

TitleAuthor(s)YearView Count
Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125bFan, NY; Tsang, FH; Tam, HKA; Au, LKS; Wong, CCL; Wei, L; Lee, MF; He, XH; Ng, IOL; Wong, CM201311
Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasisAu, LKS; Wong, CCL; Lee, MF; Fan, NY; Tsang, FH; Ng, IOL; Wong, CM201262
Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinomaFatima, S; Lee, NP; Tsang, FH; Kolligs, FT; Ng, IOL; Poon, RTP; Fan, ST; Luk, JM2012135
Up-regulation of histone methyltransferase SUV39H1 promotes liver cancer growth and metastasisFan, NY; Tsang, FH; Au, LKS; Tam, HKA; Wong, CCL; Wei, L; Lee, MF; Ng, IOL; Wong, CM201273
Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinomaLee, NP; Tsang, FH; Shek, FH; Mao, M; Dai, H; Zhang, C; Dong, S; Guan, XY; Poon, RTP; Luk, JM2010586
Clinical implication of ectopic expression of microRNA-125b in liver cancer (Poster Presentation)Tsang, FH; Luk, JMC; Lee, NPY201084
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinomaLee, NP; Chen, L; Lin, MC; Tsang, FH; Yeung, C; Poon, RT; Peng, J; Leng, X; Beretta, L; Sun, S; Day, PJ; Luk, JM2009166
The use of small peptides in the diagnosis and treatment of hepatocellular carcinomaTsang, FH; Lee, NP; Luk, JM2009109
MicroRNA-125b as a negative regulator for eukaryotic translation initiation factor 5A2 (eIF5A2) in liver cancer (Poster Presentation)Tsang, FH; Luk, JMC; Lee, NPY2009143
Roles of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma: prognostic and therapeutic implicationsLee, NPY; Tsang, FH; Mao, M; Dai, H; Poon, RTP; Luk, JMC2009103